Correlation Between Kalvista Pharmaceuticals and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Pliant Therapeutics, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Pliant Therapeutics.
Diversification Opportunities for Kalvista Pharmaceuticals and Pliant Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Kalvista and Pliant is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Kalvista Pharmaceuticals and Pliant Therapeutics
Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 0.98 times more return on investment than Pliant Therapeutics. However, Kalvista Pharmaceuticals is 1.02 times less risky than Pliant Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 517.00 in Kalvista Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 498.00 from holding Kalvista Pharmaceuticals or generate 96.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kalvista Pharmaceuticals vs. Pliant Therapeutics
Performance |
| Timeline |
| Kalvista Pharmaceuticals |
| Pliant Therapeutics |
Kalvista Pharmaceuticals and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kalvista Pharmaceuticals and Pliant Therapeutics
The main advantage of trading using opposite Kalvista Pharmaceuticals and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
| Pliant Therapeutics vs. Lyra Therapeutics | Pliant Therapeutics vs. Hookipa Pharma | Pliant Therapeutics vs. Cingulate Warrants | Pliant Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |